HomeCompareCAMPQ vs PFE

CAMPQ vs PFE: Dividend Comparison 2026

CAMPQ yields 2857.14% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CAMPQ wins by $285724556560.03M in total portfolio value
10 years
CAMPQ
CAMPQ
● Live price
2857.14%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$285724556560.08M
Annual income
$267,319,527,558,731,650.00
Full CAMPQ calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CAMPQ vs PFE

📍 CAMPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAMPQPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAMPQ + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAMPQ pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAMPQ
Annual income on $10K today (after 15% tax)
$242,857.14/yr
After 10yr DRIP, annual income (after tax)
$227,221,598,424,921,900.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, CAMPQ beats the other by $227,221,598,424,899,600.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAMPQ + PFE for your $10,000?

CAMPQ: 50%PFE: 50%
100% PFE50/50100% CAMPQ
Portfolio after 10yr
$142862278280.07M
Annual income
$133,659,763,779,378,960.00/yr
Blended yield
93.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CAMPQ
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAMPQ buys
0
PFE buys
0
No recent congressional trades found for CAMPQ or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAMPQPFE
Forward yield2857.14%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$285724556560.08M$49.6K
Annual income after 10y$267,319,527,558,731,650.00$26,258.71
Total dividends collected$284448663636.43M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CAMPQ vs PFE ($10,000, DRIP)

YearCAMPQ PortfolioCAMPQ Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$296,414$285,714.29$9,153$693.39+$287.3KCAMPQ
2$8,232,097$7,914,934.20$8,593$849.25+$8.22MCAMPQ
3$214,243,566$205,435,221.63$8,336$1,066.78+$214.24MCAMPQ
4$5,225,999,702$4,996,759,086.15$8,437$1,384.80+$5225.99MCAMPQ
5$119,502,966,841$113,911,147,159.88$9,013$1,875.40+$119502.96MCAMPQ
6$2,562,267,139,226$2,434,398,964,706.24$10,306$2,680.72+$2562267.13MCAMPQ
7$51,522,962,512,220$48,781,336,673,248.19$12,820$4,101.38+$51522962.50MCAMPQ
8$971,869,901,477,056$916,740,331,588,980.50$17,673$6,826.70+$971869901.46MCAMPQ
9$17,200,961,683,505,388$16,161,060,888,924,940.00$27,543$12,591.86+$17200961683.48MCAMPQ
10$285,724,556,560,082,430$267,319,527,558,731,650.00$49,560$26,258.71+$285724556560.03MCAMPQ

CAMPQ vs PFE: Complete Analysis 2026

CAMPQStock

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California. On June 3, 2024, CalAmp Corp. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full CAMPQ Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CAMPQ vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAMPQ vs SCHDCAMPQ vs JEPICAMPQ vs OCAMPQ vs KOCAMPQ vs MAINCAMPQ vs JNJCAMPQ vs MRKCAMPQ vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.